A Phase II Open-Label Study of TPI 287 in Patients With Breast Cancer Metastatic to the Brain.

Trial Profile

A Phase II Open-Label Study of TPI 287 in Patients With Breast Cancer Metastatic to the Brain.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2017

At a glance

  • Drugs TPI 287 (Primary) ; Dexamethasone; Diphenhydramine; Ranitidine
  • Indications Brain metastases; Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 27 Sep 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
    • 22 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top